The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical study on the second-line treatment of advanced esophageal squamous cell carcinoma with camrelizumab combined with apatinib and irinotecan: A single-arm, multicenter, phase II study.
 
Yifu He
No Relationships to Disclose
 
Chenghui Li
No Relationships to Disclose
 
Fenglin Zhang
No Relationships to Disclose
 
Bing Hu
No Relationships to Disclose
 
Yubei Sun
No Relationships to Disclose
 
Xiaoyang Xia
No Relationships to Disclose
 
Yanshun Zhang
No Relationships to Disclose
 
Gang Wang
No Relationships to Disclose
 
Tengyun Xu
No Relationships to Disclose
 
Aixiong Duan
No Relationships to Disclose
 
Shusheng Wu
No Relationships to Disclose